Evidence map›Paper›PMID 33383652›Full record

ArticleBiomolecules2020

Lipid Profile of Activated Macrophages and Contribution of Group V Phospholipase A

Masaya Koganesawa, Munehiro Yamaguchi, Sachin K Samuchiwal, Barbara Balestrieri

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Secreted Phospholipases A2: Drivers of Inflammation and Cancer.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Masaya KoganesawaDepartment of Medicine, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Munehiro YamaguchiDepartment of Medicine, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Sachin K SamuchiwalDepartment of Medicine, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Barbara BalestrieriDepartment of Medicine, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-0323-3278
Brigham and Women's Hospital · US

Funding

Group V sPLA2 in alternative activation of macrophages and pulmonary inflammationR01HL113071 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BALESTRIERI, BARBARA · 2013 to 2017
$1.9M
Group VsPLA2 in Innate Immunity and Pulmonary InflammationR56HL113071 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BALESTRIERI, BARBARA · 2019 to 2019
$400k
NHLBI NIH HHS 113071NHLBI NIH HHS R56 HL113071
6 · The paper itself

Abstract

Macrophages activated by Interleukin (IL)-4 (M2) or LPS+ Interferon (IFN)γ (M1) perform specific functions respectively in type 2 inflammation and killing of pathogens. Group V phospholipase A

Indexed as

Macrophage ActivationAnimalsCells, CulturedGroup V Phospholipases A2HumansInflammationInterleukin-4MacrophagesMicePhospholipidsGroup V Phospholipases A2Interleukin-4PhospholipidsPLA2G5 protein, humanPla2g5 protein, mouseGroup V phospholipase A2lipidsmacrophages

Identifiers

PMID33383652
PMCPMC7823364
OpenAlexW3115262832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.